Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
Price:
37
USD
-2.63%
Market Closed
Market Cap:
$58.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
B
|
British American Tobacco plc
XMUN:BMT
|
UK |
|
Unicaja Banco SA
F:7UB
|
ES |
Wall St Price Targets
TKPHF Price Forecast
Based on 18 analysts
Based on 18 analysts
+14% Upside
from
$37
today
Takeda Pharmaceutical Co Ltd (TKPHF)’s 12-month stock price forecast through September 2027 has a consensus target of $42.36, implying 14% upside. The forecast is based on price targets from 18 Wall Street analysts.
TKPHF Analyst Rating
No ratings yet
No ratings yet
Takeda Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKPHF's stock price target?
Price Target
42.36
USD
42.36
USD
According to Wall Street analysts, the average 1-year price target for TKPHF is 42.36 USD with a low forecast of 33.81 USD and a high forecast of 49.47 USD.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.